Key PointsCVS, Abbott, and UnitedHealth all yield under 5%, yet Wall Street rates each a strong buy with 40%+ upside to target.
Read the original report for the complete account of this story.
POLARIS INSIGHTS
Read the original report for the complete account of this story.